Show simple item record

dc.contributor.authorLittlejohns, Thomas J.
dc.contributor.authorKos, Katarina
dc.contributor.authorHenley, William E.
dc.contributor.authorCherubini, Antonio
dc.contributor.authorFerrucci, L
dc.contributor.authorLang, IA
dc.contributor.authorLanga, KM
dc.contributor.authorMelzer, D
dc.contributor.authorLlewellyn, DJ
dc.date.accessioned2016-02-19T14:40:59Z
dc.date.issued2015-01-01
dc.description.abstractBackground: US studies suggest that leptin, a fat-derived hormone, may be protective against the development of dementia. Objective: To investigate the complex relationship between leptin levels and cognitive decline in elderly Italians. Methods: We studied circulating fasting leptin levels in 809 elderly adults free from dementia who participated in the prospective Italian population-based InCHIANTI study between 1998 and 2009 (mean follow-up of 8.0 years). Global cognitive decline was defined as a reduction of ≥5 points on the Mini-Mental State Examination (MMSE). Trail-Making Tests A and B were also incorporated, with cognitive decline defined as discontinued testing or the worst 10% of change from baseline. We also investigated whether any association could be explained by midlife weight and whether cognitive decline was associated with changing leptin levels. Results: The multivariate adjusted relative risk ([RR]; 95% confidence interval [CI]) of cognitive decline on the MMSE was 0.84 (95% CI 0.73–0.97) in relation to baseline sex-standardized log-leptin levels. High leptin levels showed a non-significant trend toward a reduced risk of decline on the Trail-Making Tests A (RR = 0.85, 95% CI 0.71–1.02) and B (RR = 0.90, 0.79–1.02). Adjusting for midlife weight or change in weight did not alter the pattern of results, and cognitive decline was not associated with changing leptin levels. Conclusions: High leptin levels were independently associated with a reduced risk of cognitive decline in elderly Italians.en_GB
dc.description.sponsorshipItalian Ministry of Healthen_GB
dc.description.sponsorshipU.S. National Institute on Agingen_GB
dc.description.sponsorshipAlzheimer’s Associationen_GB
dc.description.sponsorshipNational Institute for Health Research (NIHR)en_GB
dc.description.sponsorshipNational Institute of Health (Baltimore)en_GB
dc.description.sponsorshipNational Institute of Health (Maryland)en_GB
dc.description.sponsorshipMary Kinross Charitable Trusten_GB
dc.description.sponsorshipJames Tudor Foundationen_GB
dc.description.sponsorshipHalpin Trusten_GB
dc.description.sponsorshipSir Halley Stewart Trusten_GB
dc.description.sponsorshipAge Related Diseases and Health Trusten_GB
dc.description.sponsorshipNorman Family Charitable Trusten_GB
dc.identifier.citationVol. 44, Issue 4, pp. 1231 - 1239en_GB
dc.identifier.doi10.3233/JAD-141836
dc.identifier.grantnumberICS110.1/RF97.71en_GB
dc.identifier.grantnumberContract: 263en_GB
dc.identifier.grantnumberContract: 9164en_GB
dc.identifier.grantnumberContract: 821336en_GB
dc.identifier.grantnumberN.1-AG-1-1en_GB
dc.identifier.grantnumberN.1-AG-1- 2111en_GB
dc.identifier.grantnumberN01-AG-5-0002en_GB
dc.identifier.grantnumberNIRG-11-200737en_GB
dc.identifier.other06665306116808R6
dc.identifier.urihttp://hdl.handle.net/10871/19978
dc.language.isoenen_GB
dc.publisherIOS Pressen_GB
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/25502764en_GB
dc.rights© 2015 – IOS Press and the authors. All rights reserved. This article is published online with Open Access and distributed under the terms of the Creative Commons Attribution Non-Commercial License.en_GB
dc.subjectAdipokinesen_GB
dc.subjectcognitive declineen_GB
dc.subjectcohort analysisen_GB
dc.subjectepidemiologyen_GB
dc.subjectleptinen_GB
dc.titleSerum leptin and risk of cognitive decline in elderly italians.en_GB
dc.typeArticleen_GB
dc.date.available2016-02-19T14:40:59Z
dc.identifier.issn1387-2877
exeter.place-of-publicationNetherlands
dc.identifier.journalJournal of Alzheimer's Diseaseen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record